Cupid Share Price Target 2026 Analyst Forecast Bull and Bear Case

Cupid (NSE: CUPID) is a Contraceptives and Healthcare Products company trading at Rs 164.89 with a market capitalisation of Rs 824 crore. Analysts have set the Cupid share price target at Rs 200 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.

Click Here – Get Free Investment Predictions

Cupid Share Price Target 2026: Key Takeaways

• Cupid share price target 2026: Rs 200 (20% upside from CMP Rs 164.89)
• Bull case: Rs 240 | Bear case: Rs 130
• Ticker: CUPID | Sector: Contraceptives and Healthcare Products | MCap: Rs 824 crore
• 52W range: Rs 114 to Rs 270 | PE: 20x
• Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
• Key risk: FY27 earnings miss or FII outflows from Indian equities

Cupid Company Overview

Cupid (NSE: CUPID) is a Nashik-based WHO pre-qualified manufacturer of male condoms, female condoms, and lubricants supplying to UNFPA, government health programs, and retail pharmacy chains across India and 30-plus countries. At CMP Rs 164.89 against a 52 week range of Rs 114 to Rs 270, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 824 crore with trailing PE of 20x. Compared to peers in healthcare products like HLL Lifecare and Mankind Pharma, Cupid is positioned as a potential re-rating candidate toward the Rs 200 price objective on FY27 earnings delivery.

Parameter	Value
NSE Ticker	CUPID
Sector	Contraceptives and Healthcare Products
CMP (2026)	Rs 164.89
52 Week High	Rs 270
52 Week Low	Rs 114
Market Cap	Rs 824 crore
Trailing PE	20x
12-Month Analyst Target	Rs 200
Bull Case Target	Rs 240
Bear Case Target	Rs 130

Why Is the Cupid Share Price Target Set at Rs 200 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Cupid share price target of Rs 200 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 164.89. The Rs 200 price objective represents the base case with FY27 execution as the key variable.

Structural Sector Tailwinds in Contraceptives and Healthcare Products

The Contraceptives and Healthcare Products sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Cupid’s market position among peers in healthcare products like HLL Lifecare and Mankind Pharma creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 240 bull case to materialise.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Cupid’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 200 analyst consensus.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable policy backdrop for Cupid’s Contraceptives and Healthcare Products operations, improving the probability of achieving the FY27 earnings targets that support the Rs 200 price objective.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 20x PE, Cupid is positioned as a beneficiary of institutional reallocation, providing a tailwind toward the Rs 240 bull case over the medium term.

Cupid Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Cupid Share Price Target

Near-term support for Cupid is anchored close to the 52 week low of Rs 114. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors can use the 52 week low as an entry reference while awaiting FY27 earnings confirmation.

12-Month Cupid Share Price Target 2026

The 12-month Cupid share price target 2026 is Rs 200, implying approximately 20 percent upside from CMP Rs 164.89. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Track live on NSE ticker CUPID.

Long Term Cupid Share Price Target: FY27 to FY28

The long term Cupid share price target for FY27 to FY28 is Rs 240 in the bull case, requiring full earnings delivery, re-rating among peers in healthcare products like HLL Lifecare and Mankind Pharma, and sustained institutional buying over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Cupid in 2026

Bull Case Cupid Share Price Target: Rs 240

The bull case Cupid share price target of Rs 240 materialises when FY27 earnings beat analyst estimates, Contraceptives and Healthcare Products tailwinds accelerate, and FII flows return strongly to Indian equities, enabling re-rating toward higher peer multiples. From CMP Rs 164.89, this represents approximately 45 percent potential upside.

Bear Case Cupid Share Price Target: Rs 130

The bear case Cupid share price target of Rs 130 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of the 52 week low support near Rs 114.

Scenario	Target	Key Conditions
Bull Case	Rs 240	FY27 beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 200	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 130	FY27 miss, guidance cut, FII outflows

Key Risks That Could Derail the Cupid 2026 Price Objective

Global Macro and US Tariff Headwinds

Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Cupid share price target of Rs 200, with FII outflows being the direct transmission mechanism to Indian equity valuations.

FY27 Earnings Miss and Guidance Risk

An FY27 earnings miss or downward guidance revision would compress valuation multiples. This is the most direct company-specific risk to the Rs 200 analyst price objective. Investors must monitor quarterly results and management commentary closely.

Competitive Intensity Among Contraceptives and Healthcare Products Peers

Intensifying competition from peers in healthcare products like HLL Lifecare and Mankind Pharma could compress Cupid’s market share and pricing power. This structural risk must be weighed when assessing the defensibility of the earnings trajectory that underpins the Rs 200 analyst target for 2026.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should size positions carefully and maintain stop losses to protect capital if broad market de-rating continues.

How to Invest in Cupid

Check the Univest Screener for live data

Before considering any investment based on the Cupid share price target of Rs 200, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Contraceptives and Healthcare Products sector demand and competition.

Open a Demat account with a SEBI registered stockbroker to trade Cupid (NSE: CUPID) with regulatory protection. Study the competitive landscape among peers in healthcare products like HLL Lifecare and Mankind Pharma before executing any position.

Plan your entry using the 52 week low of Rs 114 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 200 price target. Always set a stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Contraceptives and Healthcare Products space where sectoral cycles can amplify volatility beyond initial expectations.

Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Cupid’s live share price and receive daily stock recommendations.

FAQs on Cupid Share Price Target 2026

What is the Cupid share price target for 2026?

Ans. The Cupid share price target 2026 is Rs 200, implying approximately 20 percent upside from CMP Rs 164.89. Bull case is Rs 240, bear case is Rs 130.

What was the Cupid share price target for 2025?

Ans. The 2025 price objective for Cupid was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 200, reflecting FY27 growth potential from CMP Rs 164.89.

Is Cupid a good investment at Rs 164.89?

Ans. At Rs 164.89, Cupid offers potential upside toward Rs 200 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing based on any price target.

What are the key risks to the Cupid share price target 2026?

Ans. Key risks to the Cupid share price target of Rs 200 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Contraceptives and Healthcare Products. Monitoring quarterly results is essential.

What is the 52 week high and low of Cupid?

Ans. The 52 week high of Cupid is Rs 270 and the 52 week low is Rs 114. At CMP Rs 164.89, the stock is below its 52 week high and offers upside toward the Rs 200 price objective.

What are the main growth catalysts for Cupid in 2026?

Ans. Key catalysts include FY27 PAT recovery, Contraceptives and Healthcare Products tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Cupid compare to its peers?

Ans. Cupid operates in Contraceptives and Healthcare Products alongside peers in healthcare products like HLL Lifecare and Mankind Pharma. At CMP Rs 164.89 with MCap Rs 824 crore, it is a potential re-rating candidate toward the Cupid share price target of Rs 200 on FY27 delivery.

What is the Cupid share price target for 2027?

Ans. The long-term Cupid share price target for FY27 to FY28 is Rs 240 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.